Supergut Review 2026: $60 for 6 Grams of Fiber With a Hormone's Name On It

The product is a fiber powder, mixed into 8–12 oz of liquid. Supergut is straightforward about the composition, which we appreciate.

Solnul® is the branded, patented ingredient here — a resistant potato starch from MSP Starch Products. It has a genuine, published, peer-reviewed randomised controlled trial behind it, which puts it ahead of most supplement ingredients on the market. Here is that trial. 75 participants, randomised double-blind against a corn starch placebo, 3.5 g/day or 7 g/day for 4 weeks, published in *Nutrients* in 2023. What it measured: the relative abundance of *Bifidobacterium* and *Akkermansia* by 16S rRNA sequencing, and stool consistency on the Bristol Stool Form Scale. Secondary endpoints were diarrhoea- and constipation-associated bowel movements. What it found: the 3.5 g dose significantly increased *Bifidobacterium* (p=0.038) and *Akkermansia* (p=0.014) versus placebo, and significantly reduced both diarrhoea- and constipation-associated bowel movements. The 7 g dose performed about the same as 3.5 g — more was not better. That is a legitimate prebiotic result, and it is a good one. It supports the digestion and regularity claims completely. What the trial did not measure: GLP-1. Or body weight. Neither appears among the outcomes. The study was designed to answer a microbiome question, and it answered it well. It was not designed to answer the question printed on the front of the product, and it does not.

Beyond the ingredient literature, Supergut cites its own research. The footnote on the product page reads: "Supergut and Tiny Health Foundational Pilot Clinical Study; Supergut and Tiny Health Observational Study, 2026. Some results are based on self-reported data and may vary." Take that apart, because the wording is doing a lot of work. A pilot study is, by design, not a test of efficacy. Pilots exist to check feasibility, recruitment and dosing before a real trial. They are typically small, frequently uncontrolled, and are not the basis on which you should conclude a product works. An observational study does not randomise anyone. Everyone who enrols has already chosen to buy and use the product, which means the people in it are systematically different from people who did not — more motivated, more likely to be changing other things at the same time. And "some results are based on self-reported data" means people were asked how they felt. Self-report on an unblinded product you have paid for is where placebo effects live. None of this is fraudulent, and running a pilot with a microbiome testing company is more effort than most brands make. But it is the weakest available class of evidence, cited in support of the strongest available implication, and no results from either study are published on the page for you to check.

This is the number that explains the entire over-the-counter GLP-1 category, and once you have it, every product in it makes more sense. The GLP-1 your body makes has a half-life of roughly two minutes. It is degraded almost immediately by an enzyme called DPP-4. That is by design: endogenous GLP-1 is a short, sharp meal signal. It spikes after you eat, does its job, and is gone. Semaglutide has a half-life of about a week. Roughly 165 hours. That single structural difference — resistance to DPP-4 degradation, plus albumin binding — is the entire pharmacological achievement of these drugs. It is why one injection covers seven days, and why receptors stay activated continuously rather than in brief post-meal pulses. So when a product promises to "support natural GLP-1 levels," understand what is on offer: a modestly larger version of a signal your body already produces at every meal and destroys within minutes. Not a sustained, week-long, supraphysiologic receptor activation. That is not a small difference in degree. It is the difference between the two things. Fiber is still worth eating. More fiber means better satiety, better glycaemic response, better bowel function, better cholesterol, and a better microbiome — the trial above demonstrates the last one directly. Those benefits are real and worth having on their own terms. They are simply not the benefit the product name evokes.

Here is the calculation that should decide this purchase, and it takes thirty seconds. You are short roughly 10–20 grams of fiber a day against the recommended intake. Supergut supplies 6–7 grams. So it closes somewhere between a third and half of a typical gap, at $45–$120 a month. Now the same gap, filled other ways:

It is a reasonable buy if: you know you eat too little fiber and have not managed to fix that with food; you want a well-formulated blend rather than plain psyllium and will pay a premium for palatability and format; or you have digestive complaints — irregularity, alternating constipation and loose stools — where the Solnul trial's actual findings apply directly to you. It is a reasonable adjunct if you are already on a GLP-1 medication. Constipation is one of the most common complaints on semaglutide and tirzepatide, and added soluble fiber is a sensible, low-risk response to it. Buy it for the constipation, which is well supported, not for extra weight loss, which is not. Skip it if: you are buying it as an alternative to prescription GLP-1 therapy — the mechanism is real but the magnitude is not in the same category; you are already eating 25–30 g of fiber a day, in which case you are buying a solution to a problem you do not have; or the $60 matters to you, because psyllium, chia, oats and beans do the same job for a fraction of the price. Start low regardless. Going from 15 g of fiber a day to 22 g overnight produces gas, bloating and cramping in a lot of people. Half a scoop for the first week, with more water than you think you need, is the way to avoid concluding that a perfectly good product does not agree with you.

Does Supergut actually boost GLP-1? Fermentable fiber does stimulate endogenous GLP-1 release — that mechanism is well established. But Supergut's own branded ingredient trial did not measure GLP-1, and the company's only cited product research is an unpublished pilot and an observational survey with self-reported results. The mechanism is real; the product-specific evidence for it is not published. Is Supergut the same as Ozempic? No, and not close. Native GLP-1 has a half-life of about two minutes; semaglutide's is about a week. Fiber produces brief post-meal pulses of a hormone your body clears almost immediately. GLP-1 agonist drugs produce continuous receptor activation. What is Solnul? A branded resistant potato starch from MSP Starch Products. Its published trial — 75 people, 4 weeks, 3.5 g or 7 g daily — showed significant increases in Bifidobacterium and Akkermansia and fewer diarrhoea- and constipation-associated bowel movements versus placebo. It did not measure GLP-1 or body weight. How much fiber is in it? 6–7 grams per serving. Recommended daily intake is roughly 25 g for women and 38 g for men; the average American gets about 15 g. Will it help me lose weight? There is no published trial of Supergut showing weight loss. Higher fiber intake is associated with modestly better weight outcomes in the general nutrition literature, mostly through satiety. Expect that scale of effect, which is small. Can I take it with semaglutide or tirzepatide? Generally yes, and it may help with GLP-1-related constipation. Separate it from oral medications by a couple of hours, since soluble fiber can slow the absorption of other drugs, and mention it to your prescriber. What are the side effects? Gas, bloating and cramping when you increase fiber too quickly. Start with half a serving and increase over one to two weeks, with plenty of water. Is $60 reasonable? For a well-made fiber blend, it is a premium price but not an outrageous one. For the GLP-1 outcome the name implies, it is expensive fiber.